News

Scripps Research scientists direct bacteria with expanded genetic code to evolve extreme heat tolerance.

Scientists at Scripps Research have found an important immune system-regulating protein that in principle could be targeted to treat cancers and chronic viral infections.

A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.

A concerned Texas mom finally has answers about the cause of her son’s sensory-processing problems thanks to a special collaboration among her patient-advocacy group and the lab of Scripps Research Neuroscientist Gavin Rumbaugh, PhD.

It’s a common expression to say that your brain is full. Although the brain doesn’t literally fill up, in recent years researchers have discovered that the brain does sometimes push out old memories in order to take up new ones.

The Society of Research Fellows at Scripps Research in Florida named chemist Hans Renata, PhD, the Outstanding Mentor for 2018 in recognition of his dedication to his students and postdoctoral fellows. Renata’s lab members say he embodies both patience and high expectations.

IVD Research Inc., a contract development and manufacturing (CDMO)  firm in Carlsbad, California has licensed a novel biomarker for onchocerciasis—better known as river blindness—from Scripps Research in La Jolla, California. The reagent, developed in the laboratory of Kim Janda, PhD, a professor of chemistry at Scripps Research, will allow clinicians to monitor active infections of onchocerciasis.

Scientists at Scripps Research have discovered that a mysterious family of cellular proteins called OSCAs and TMEM63s are a novel class of mechanosensitive ion channels.

Scripps Research enjoys a worldwide reputation for producing innovative, high-quality research. Now, the institute’s Scripps Fellows program is identifying the next generation of scientific leaders and setting them up to launch impactful careers.

When ribosomes malfunction, disease is not far behind.

This is the first time four antibodies have been tethered together and tried against influenza.

Scientists at Scripps Research have made a surprising discovery in their mission to understand how cells stay healthy, uncovering an important connection between a cell’s sugar metabolism and its antioxidant response.

The funding will support research in the Stowers lab to describe a complete neural circuit in a mammalian brain—a first for science.

New insight into how cells sense blood pressure could present better targets for treating hypertension.

Scripps Research scientists use the tools of synthetic biology to engineer organisms similar to those thought to have lived billions of years ago

The partnership seeks to accelerate the application of artificial intelligence for disease prevention, health promotion and the streamlining of biomedical research efforts.

"It’s as if they link arms together to form a stronger complex..."

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

Disney’s research has changed how scientists approach so-called “undruggable” diseases.

Predictors of future diabetes and cardiovascular disease for a person with obesity can be found among their body's metabolites.

New understanding of cell biology could give scientists a potential way to tackle cancer cells. 

Researchers identify the protein responsible for allodynia, a kind of pain that follows gentle touch.

Founding members will help guide academic, scientific and business strategies.

Lorraine S. Evangelista, PhD, RN, has joined the Scripps Research Translational Institute as associate scientific director for the All of Us Research Program’s Participant Center.